What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines
Figure 7
Effect of initial efficacy on effectiveness of all vaccines for different transmission settings delivered via EPI (BSV (a–c), BSV/TBV (d–f), PEV (g–i), PEV/TBV (j–l), BSV/PEV (m–o) and BSV/TBV (p–r)).
Results obtained assuming a vaccine half-life of 10 years and homogeneity value of 10.